Michael Hayden
2017
In 2017, Michael Hayden earned a total compensation of $4.2M as Former President of Global R&D and Chief Scientific Officer at Teva Pharmaceutical Industries, a 44% decrease compared to previous year.
Compensation breakdown
| Option Awards | $666,686 |
|---|---|
| Salary | $1,071,000 |
| Stock Awards | $1,333,315 |
| Other | $1,152,537 |
| Total | $4,223,538 |
Hayden received $1.3M in stock awards, accounting for 32% of the total pay in 2017.
Hayden also received $666.7K in option awards, $1.1M in salary and $1.2M in other compensation.
Rankings
In 2017, Michael Hayden's compensation ranked 2,388th out of 14,666 executives tracked by ExecPay. In other words, Hayden earned more than 83.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,388 out of 14,666 | 84th |
Division Manufacturing | 839 out of 5,772 | 86th |
Major group Chemicals And Allied Products | 222 out of 2,075 | 89th |
Industry group Drugs | 169 out of 1,731 | 90th |
Industry Pharmaceutical Preparations | 134 out of 1,333 | 90th |
Source: SEC filing on April 25, 2018.
Hayden's colleagues
We found nine more compensation records of executives who worked with Michael Hayden at Teva Pharmaceutical Industries in 2017.
2017
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Yitzhak Peterburg
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Rob Koremans
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Carlo de Notaristefani
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2017
Eyal Desheh
Teva Pharmaceutical Industries
Chief Financial Officer
2017
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2017
Erez Vigodman
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Mark Sabag
Teva Pharmaceutical Industries
Executive Vice President, Global Human Resources
2017
Michael McClellan
Teva Pharmaceutical Industries